# ECT vs. Esketamine

> **NCT04924257** · PHASE3 · WITHDRAWN · sponsor: **Medical University Innsbruck**

## Conditions studied

- Treatment Resistant Depression
- Major Depressive Disorder

## Interventions

- **DRUG:** Esketamine nasal spray
- **PROCEDURE:** Electroconvulsive therapy

## Key facts

- **NCT ID:** NCT04924257
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-07-28
- **Primary completion:** 2023-08
- **Final completion:** 2024-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible participants
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04924257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04924257, "ECT vs. Esketamine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04924257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*